Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Guylaine Haché

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Journal of Virology|March 2, 2012
Differentiation-dependent changes in levels of C/EBPβ repressors and activators regulate human papillomavirus type 31 late gene expressionVignesh Gunasekharan, Guylaine Haché, Laimonis Laimins
The Journal of Biological Chemistry|January 14, 2005
The retroviral hypermutation specificity of APOBEC3F and APOBEC3G is governed by the C-terminal DNA cytosine deaminase domainGuylaine Haché, Mark T Liddament, Reuben S Harris
AIDS Reviews|November 3, 2006
Human APOBEC3 proteins, retrovirus restriction, and HIV drug resistanceGuylaine Haché, Louis M Mansky, Reuben S Harris
Current Biology : CB|May 27, 2008
Evolution of HIV-1 isolates that use a novel Vif-independent mechanism to resist restriction by human APOBEC3GGuylaine Haché, Keisuke Shindo, John S Albin, et al.
Journal of Virology|March 20, 2009
Optimal translation initiation enables Vif-deficient human immunodeficiency virus type 1 to escape restriction by APOBEC3GGuylaine Haché, Truus E M Abbink, Ben Berkhout, et al.
Journal of Virology|August 6, 2010
Long-term restriction by APOBEC3F selects human immunodeficiency virus type 1 variants with restored Vif functionJohn S Albin, Guylaine Haché, Judd F Hultquist, et al.
Journal of Virology|January 11, 2008
The DNA deaminase activity of human APOBEC3G is required for Ty1, MusD, and human immunodeficiency virus type 1 restrictionApril J Schumacher, Guylaine Haché, Donna A Macduff, et al.
Nucleic Acids Research|October 14, 2006
Evolutionarily conserved and non-conserved retrovirus restriction activities of artiodactyl APOBEC3F proteinsStefán R Jónsson, Guylaine Haché, Mark D Stenglein, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Journal of Virology|March 2, 2012
Differentiation-dependent changes in levels of C/EBPβ repressors and activators regulate human papillomavirus type 31 late gene expressionVignesh Gunasekharan, Guylaine Haché, Laimonis Laimins
The Journal of Biological Chemistry|January 14, 2005
The retroviral hypermutation specificity of APOBEC3F and APOBEC3G is governed by the C-terminal DNA cytosine deaminase domainGuylaine Haché, Mark T Liddament, Reuben S Harris
AIDS Reviews|November 3, 2006
Human APOBEC3 proteins, retrovirus restriction, and HIV drug resistanceGuylaine Haché, Louis M Mansky, Reuben S Harris
Current Biology : CB|May 27, 2008
Evolution of HIV-1 isolates that use a novel Vif-independent mechanism to resist restriction by human APOBEC3GGuylaine Haché, Keisuke Shindo, John S Albin, et al.
Journal of Virology|March 20, 2009
Optimal translation initiation enables Vif-deficient human immunodeficiency virus type 1 to escape restriction by APOBEC3GGuylaine Haché, Truus E M Abbink, Ben Berkhout, et al.
Journal of Virology|August 6, 2010
Long-term restriction by APOBEC3F selects human immunodeficiency virus type 1 variants with restored Vif functionJohn S Albin, Guylaine Haché, Judd F Hultquist, et al.
Journal of Virology|January 11, 2008
The DNA deaminase activity of human APOBEC3G is required for Ty1, MusD, and human immunodeficiency virus type 1 restrictionApril J Schumacher, Guylaine Haché, Donna A Macduff, et al.
Nucleic Acids Research|October 14, 2006
Evolutionarily conserved and non-conserved retrovirus restriction activities of artiodactyl APOBEC3F proteinsStefán R Jónsson, Guylaine Haché, Mark D Stenglein, et al.
Pageof 1